Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review
- 31 March 2021
- journal article
- review article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 61 (1) , 8-23
Abstract
Objectives: Although neuropsychiatric involvement in SLE (NPSLE) is one of the most complex and troubling manifestations of the disease, validated outcome instruments to be used as sensitive endpoints in controlled clinical trials are lacking. We performed a systematic literature review (SLR) to identify outcome measurement instruments and domains used to assess NPSLE. Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines were used. Articles available in English (1967–2020), listed in PubMed, Embase, PsycINFO, Cochrane Library and the EULAR outcome measures library were screened. All domains and outcome measurement instruments were characterized according to the OMERACT Filter 2.1, considering core areas (manifestations/abnormalities, life impact, death/lifespan, societal/resource use) and contextual factors. Results: Of 3392 abstracts evaluated, 83 studies were included in the SLR (15 974 patients, females 89.9%). Eligible studies included domains and instruments pertinent to all core areas defined by the OMERACT, except for ‘societal/resource use’. The most common core areas were ‘manifestations/abnormalities’, covering 10 domains pertinent to laboratory and instrumental markers, indexes and neuropsychiatric dimension (cognitive, neurologic and psychiatric field), and ‘life impact’, covering 7 domains related to physical function (from both the perspective of the patient and the physician), pain and quality of life. Conclusion: Our study revealed great heterogeneity in the instruments derived from populations with NPSLE and none of these had high-quality evidence. This supports the need to develop and further validate a core domain set and outcome measurement instruments to promote clinical research in this field, enhancing comparability across studies.Keywords
This publication has 94 references indexed in Scilit:
- Reduced Insular Glutamine and N-Acetylaspartate in Systemic Lupus ErythematosusAcademic Radiology, 2013
- Mesial temporal lobe epilepsy as a neuropsychiatric syndrome of systemic lupus erythematosusEpilepsia, 2012
- Unmet medical needs in systemic lupus erythematosusArthritis Research & Therapy, 2012
- Memantine in Systemic Lupus Erythematosus: A Randomized, Double-Blind Placebo-Controlled TrialSeminars in Arthritis and Rheumatism, 2011
- Rituximab in the treatment of severe lupus myelopathyClinical Rheumatology, 2011
- Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2010
- Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort studyBMC Musculoskeletal Disorders, 2010
- Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instrumentsQuality of Life Research, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous systemAnnals of the Rheumatic Diseases, 2007